Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis.

Abstract

OBJECTIVES\nEarly diagnosis of invasive aspergillosis (IA) remains challenging, with available diagnostics being limited by inadequate sensitivities and specificities. Triacetylfusarinine C, a fungal siderophore that has been shown to accumulate in urine in animal models, is a potential new biomarker for diagnosis of\xa0IA.\n\n\nMETHODS\nWe developed a method allowing absolute and matrix-independent mass spectrometric quantification of TAFC. Urine TAFC, normalized to creatinine, was determined in 44 samples from 24 patients with underlying hematologic malignancies and probable, possible or no IA according to current EORTC/MSG criteria and compared to other established biomarkers measured in urine and same-day blood samples.\n\n\nRESULTS\nTAFC/creatinine sensitivity, specificity, positive and negative likelihood ratio for probable versus no IA (cut-off\u202f≥\u202f3) were 0.86, 0.88, 6.86, 0.16 per patient.\n\n\nCONCLUSION\nFor the first time, we provide proof for the occurrence of TAFC in human urine. TAFC/creatinine index determination in urine showed promising results for diagnosis of IA offering the advantages of non-invasive sampling. Sensitivity and specificity were similar as reported for GM determination in serum and bronchoalveolar lavage, the gold standard mycological criterion for IA diagnosis.